Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cells.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
02 11 2021
Historique:
received: 02 02 2021
revised: 24 07 2021
accepted: 08 10 2021
entrez: 3 11 2021
pubmed: 4 11 2021
medline: 16 2 2022
Statut: ppublish

Résumé

Human induced pluripotent stem cells (hiPSCs) show variable differentiation potential due to their epigenomic heterogeneity, whose extent/attributes remain unclear, except for well-studied elements/chromosomes such as imprints and the X chromosomes. Here, we show that seven hiPSC lines with variable germline potential exhibit substantial epigenomic heterogeneity, despite their uniform transcriptomes. Nearly a quarter of autosomal regions bear potentially differential chromatin modifications, with promoters/CpG islands for H3K27me3/H2AK119ub1 and evolutionarily young retrotransposons for H3K4me3. We identify 145 large autosomal blocks (≥100 kb) with differential H3K9me3 enrichment, many of which are lamina-associated domains (LADs) in somatic but not in embryonic stem cells. A majority of these epigenomic heterogeneities are independent of genetic variations. We identify an X chromosome state with chromosome-wide H3K9me3 that stably prevents X chromosome erosion. Importantly, the germline potential of female hiPSCs correlates with X chromosome inactivation. We propose that inherent genomic properties, including CpG density, transposons, and LADs, engender epigenomic heterogeneity in hiPSCs.

Identifiants

pubmed: 34731633
pii: S2211-1247(21)01382-6
doi: 10.1016/j.celrep.2021.109909
pii:
doi:

Substances chimiques

DNA Transposable Elements 0
Histones 0
RNA, Long Noncoding 0
XIST non-coding RNA 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109909

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Shihori Yokobayashi (S)

Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan. Electronic address: yokobayashi@anat2.med.kyoto-u.ac.jp.

Yukihiro Yabuta (Y)

Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Masato Nakagawa (M)

Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Keisuke Okita (K)

Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Bo Hu (B)

Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Department of Human Genetics, McGill University, Montreal, QC H3A 1C7, Canada.

Yusuke Murase (Y)

Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Tomonori Nakamura (T)

Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Guillaume Bourque (G)

Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Department of Human Genetics, McGill University, Montreal, QC H3A 1C7, Canada.

Jacek Majewski (J)

Department of Human Genetics, McGill University, Montreal, QC H3A 1C7, Canada.

Takuya Yamamoto (T)

Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; AMED-CREST, AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan; Medical-risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto 606-8507, Japan.

Mitinori Saitou (M)

Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Knoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH